Matthew J. Bucher

Matthew J. Bucher serves as a key procurement professional within the Naval Medical Logistics Command (N62645), supporting the Department of Defense’s mission to sustain combat-ready medical forces through the acquisition of critical medical logistics assets. He specializes in managing complex contract actions for surgical and diagnostic equipment, life-sustaining medical supplies, and advanced point-of-care diagnostic systems. His work ensures the timely delivery of mission-critical medical capabilities to global operational theaters, aligning procurement strategy with the Navy and Marine Corps’ clinical and tactical readiness requirements. Bucher routinely handles full-and-open and small business set-aside acquisitions under FAR Part 13 and Part 15 procedures, emphasizing performance-based contracting and lifecycle sustainment. While specific contractor names are not available, Bucher maintains a robust network of vendors specializing in medical device manufacturing and biomedical R&D. His procurement patterns reflect engagement with both established defense medical suppliers and innovative small businesses capable of delivering FDA-cleared or CE-marked medical technologies. He fosters collaborative vendor relationships grounded in technical compliance, supply chain resilience, and rapid response capabilities essential for forward-deployed medical units. Bucher demonstrates a strong preference for small business participation, with approximately one-third of his acquisitions structured as Total Small Business Set-Asides under FAR 19.5. His contracting approach prioritizes socioeconomic programs that enable qualified small businesses to compete for high-impact medical logistics contracts, reflecting a deliberate commitment to broadening the industrial base and enhancing innovation through diverse vendor engagement. His primary procurement focus lies in NAICS 339112 (Surgical and Medical Instrument Manufacturing), where he acquires reusable and disposable clinical tools, surgical kits, and diagnostic instrumentation. He also supports NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences), facilitating the development of next-generation medical technologies tailored to battlefield medicine. Bucher’s expertise centers on procuring technically complex, regulated medical products requiring rigorous validation, traceability, and compliance with DoD and FDA standards.